Strategy exploration on strengthening the translation of scientific and technological achievements for stem cell
10.3760/cma.j.cn113565-20200327-00107
- VernacularTitle:加强干细胞科技成果转化的策略探讨
- Author:
Qinghui ZHAO
1
;
Erpeng JIANG
;
Bin HE
;
Hongming TANG
;
Zhongmin LIU
Author Information
1. 同济大学附属东方医院干细胞转化医学产业基地 国家干细胞转化资源库 上海干细胞临床转化研究院 上海市干细胞临床诊疗工程研究中心，上海 200123
- From:
Chinese Journal of Medical Science Research Management
2020;33(4):264-268
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study aims to analyze and summarize the current status and existing problems of stem cell research, and explore possible measures to strengthen the translation of scientific and technological achievements for stem cell in China.Methods:To study and analyze the current status of stem cell planning and policy, basic research, clinical research and clinical trials, as well as drug development, summarize the factors that affect the translation of stem cell scientific and technological achievements.Results:Combined with the practice and exploration of author in recent ten years, it is suggested to promote the translation and clinical application of scientific and technological achievements for stem cell from six aspects, including regulatory policy, resource collection, clinical research, the collaboration of institutes and enterprises, project incubation as well as risk prevention and control.Conclusions:Strengthening translation and clinical application of scientific and technological achievements for stem cell could not only meet the needs of Chinese economic and social development, but also contribute to the "Healthy China 2030" national strategy. It is of great practical significance to speed up the translation from a follower to a leader in stem cell industry globally, improve the core competitiveness and seize the commanding heights of the stem cell industry in the word.
